Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.77%
SPX
+0.83%
IXIC
+0.98%
FTSE
+0.42%
N225
+0.81%
AXJO
+0.38%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
287.05M
Dividend Yield
0.00%
P/E Ratio
-4.10
EPS
-1.15
Revenue
22.27M
Avg. Volume
926.78K

Recently from Cashu

publisher logo
Cashu

Capricor Therapeutics Faces Class Action Over Misleading Deramiocel Statements

4 days ago
publisher logo
Cashu

Capricor Therapeutics Under Legal Scrutiny Over Transparency in Drug Development Claims

5 days ago
publisher logo
Cashu

Capricor Therapeutics Under Legal Scrutiny Over Deramiocel Data Disclosure Allegations

7 days ago

About

What does CAPR do?
Capricor Therapeutics, based in Beverly Hills, develops biological therapies for serious medical conditions, focusing on CAP-1002 for Duchenne muscular dystrophy in Phase 3 trials. The company also utilizes exosome technology for various therapeutic applications.
Sector
💻 Health Care
IPO
CEO
Employees
160
Headquarters
California, USA
Website
http://www.capricor.com
Stocks
Health Care
capr
Capricor Therapeutics
NASDAQ: CAPR
-0.33 (-5.25%)
5.95
USD
At close at Sep 04, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials